Accountable healthcare: a conversation with Morgan Health’s Dan Mendelson
How employers have the ability, and responsibility, to reduce healthcare disparities, improve quality and lower the costs of healthcare
By Steve Usdin, Washington Editor
July 28, 2022 1:55 PM UTC
Employers have the ability, and share a responsibility, to reduce healthcare disparities, improve quality and lower the costs of healthcare for the 150 million employees who rely on companies for healthcare coverage, Dan Mendelson, CEO of Morgan Health, told The BioCentury Show.
Mendelson took on leadership of Morgan Health when the JPMorgan Chase unit was founded in May 2021. The company has $250 million to invest in companies that address the needs of JPMorgan Chase’s employees and of other Americans covered by employers. The company’s first investments are in companies that are advancing accountable care.
Prescription drugs account for about a quarter of JPMorgan’s healthcare costs and are one of the most rapidly increasing costs, Mendelson said. Morgan Health will pivot next year to investments that are intended to increase the value of its drug spend, he added.
Mendelson, who founded and served as CEO of Avalere, a leading health consulting firm, and as associate director for health at the Office of Management and Budget in the Clinton administration, also discussed current and future attempts by Congress to regulate drug prices, the need to balance incentives for biomedical innovation with policies that ensure access, and the response of JPMorgan to the Supreme Court’s decision to overturn Roe v. Wade.
